Notice: This company has been marked as potentially delisted and may not be actively trading. Vallon Pharmaceuticals (VLON) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Questcor Pharmaceuticals,July 21, 2023 | forbes.comVallon Pharmaceuticals' shareholders approve reverse merger with California companyApril 20, 2023 | bizjournals.comVallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock SplitApril 20, 2023 | finance.yahoo.comVallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until April 20, 2023April 12, 2023 | finance.yahoo.comLab Notes: CHOP gets $10M research gift; Vallon seeks greater shareholder support for mergerApril 7, 2023 | bizjournals.comVallon Pharmaceuticals Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio and Urges Stockholders of Record as of March 6, 2023 to Vote by April 11, 2023, at 11:59 PM ETApril 4, 2023 | finance.yahoo.comVallon Pharmaceuticals Inc.: Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial ResultsFebruary 24, 2023 | finanznachrichten.deVallon Pharmaceuticals Reports Fiscal Year 2022 Financial ResultsFebruary 24, 2023 | finance.yahoo.comIs Vallon Pharmaceuticals Inc (VLON) recent surge justifiedFebruary 14, 2023 | benzinga.comTrading was temporarily halted for "VLON" at 09:02 AM with a stated reason of "LULD pause."February 13, 2023 | marketbeat.comVallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch EventJanuary 11, 2023 | finance.yahoo.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vallon Pharmaceuticals, Inc. - VLONDecember 27, 2022 | benzinga.comVallon Pharmaceuticals to merge with California biotech firm in 'best path forward'December 14, 2022 | bizjournals.comWhat's Going On With Vallon Pharmaceuticals Stock Today?December 14, 2022 | msn.comWhy Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving PremarketDecember 14, 2022 | benzinga.comVallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell RegulatorsDecember 13, 2022 | finance.yahoo.comTrading was temporarily halted for "VLON" at 04:12 PM with a stated reason of "News pending."December 13, 2022 | marketbeat.comVallon Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNovember 3, 2022 | finance.yahoo.comVallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateJuly 28, 2022 | finance.yahoo.comVallon Pharmaceuticals, Inc. (VLON)July 20, 2022 | finance.yahoo.comVallon Pharmaceuticals plans $3.9M stock sale to support exploration of strategic alternativesMay 16, 2022 | bizjournals.comVallon Pharmaceuticals to raise $3.9M in stock offeringMay 13, 2022 | seekingalpha.comVallon Pharmaceuticals Announces $3.9 Million Registered Direct OfferingMay 13, 2022 | finance.yahoo.comVallon Pharma Posts Additional Data From SEAL Study Of Formulated CNS StimulantMay 12, 2022 | finance.yahoo.comVallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIRMay 12, 2022 | finance.yahoo.comVallon Pharmaceuticals Announces Issuance of Japanese Patent Covering Composition of Matter and Methods of Manufacturing for ADAIRMay 11, 2022 | finance.yahoo.comVallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateMay 9, 2022 | finance.yahoo.comVallon Pharma Up 85% In Pre-market On Exploring Strategic AlternativesApril 22, 2022 | markets.businessinsider.comVallon stock surges on review of strategic alternativesApril 22, 2022 | seekingalpha.comVallon Shares Soar Premarket After Company Hangs 'For Sale' Sign >VLONApril 22, 2022 | marketwatch.comVallon Pharmaceuticals stock skyrockets after move to 'evaluate strategic alternatives'April 22, 2022 | bizjournals.comWhy Are Vallon Pharma Shares Surging TodayApril 22, 2022 | finance.yahoo.comVallon Pharmaceuticals Announces Review of Strategic AlternativesApril 22, 2022 | finance.yahoo.comVallon (VLON) Plummets as ADAIR Study Misses Primary GoalMarch 22, 2022 | nasdaq.comMid-Afternoon Market Update: Dow Tumbles 300 Points; Vallon Pharmaceuticals Shares PlungeMarch 21, 2022 | markets.businessinsider.comVallon says its abuse-deterrent ADHD drug candidate didn't work in a clinical trialMarch 21, 2022 | morningstar.comVallon crashes after lead program for ADHD candidate did not meet main goalMarch 21, 2022 | seekingalpha.comWhy Vallon Pharma Stock Falling In Pre-market?March 21, 2022 | nasdaq.comVallon Pharmaceuticals stock plunges 70% after ADHD drug candidate misses primary endpointMarch 21, 2022 | finance.yahoo.comVallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHDMarch 21, 2022 | finance.yahoo.comTrading was temporarily halted for "VLON" at 06:03 AM with a stated reason of "News pending."March 21, 2022 | marketbeat.comVallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of DirectorsFebruary 28, 2022 | finance.yahoo.comVallon Pharmaceuticals Announces Issuance of U.S. Patent Covering ADAIR for the Treatment of Cognitive Impairment Associated with COVID-19February 28, 2022 | finance.yahoo.comVallon Pharmaceuticals reports FY resultsFebruary 14, 2022 | seekingalpha.comVallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results and Provides Business UpdateFebruary 14, 2022 | finance.yahoo.comEven with Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) stock down 13% this week, insiders who bought recently netted around US$20kJanuary 25, 2022 | finance.yahoo.comTrading was temporarily halted for "VLON" at 11:01 AM with a stated reason of "LULD pause."January 24, 2022 | marketbeat.comVallon Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks ConferenceJanuary 20, 2022 | finance.yahoo.comVallon Pharmaceuticals Presents New Data from Adult Stimulant Abuse Pattern Survey at the APSARD 2022 Annual ConferenceJanuary 18, 2022 | finance.yahoo.comVallon Pharmaceuticals Inc Shares Close the Week 25.6% Higher - Weekly WrapJanuary 10, 2022 | nasdaq.com Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address VLON Media Mentions By Week VLON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VLON News Sentiment▼0.000.74▲Average Medical News Sentiment VLON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VLON Articles This Week▼00▲VLON Articles Average Week Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CPIX News VRCA News XLO News BIVI News RNXT News IXHL News XCUR News LEXX News MRNS News CMMB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VLON) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vallon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vallon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
